AR094658A1 - Formulación de sales de rehidratación liposomal - Google Patents
Formulación de sales de rehidratación liposomalInfo
- Publication number
- AR094658A1 AR094658A1 ARP140100123A ARP140100123A AR094658A1 AR 094658 A1 AR094658 A1 AR 094658A1 AR P140100123 A ARP140100123 A AR P140100123A AR P140100123 A ARP140100123 A AR P140100123A AR 094658 A1 AR094658 A1 AR 094658A1
- Authority
- AR
- Argentina
- Prior art keywords
- salts
- formulation
- liposomal rehydration
- concentration
- rehydration salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 1
- 239000001508 potassium citrate Substances 0.000 abstract 1
- 229960002635 potassium citrate Drugs 0.000 abstract 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 abstract 1
- 235000011082 potassium citrates Nutrition 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
- A23L2/74—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration using membranes, e.g. osmosis, ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Una formulación de sales de rehidratación liposomal que comprende liposomas de fosfatidilcolina, antioxidante, sales, agua, y una relación de inclusión porcentual de sales (sales retenidas dentro de dichos liposomas/sales totales) de al menos 40% y un proceso para su elaboración que utiliza la ultrafiltración tangencial. Reivindicación 5: La formulación de la reivindicación 1 caracterizada porque dichas sales son seleccionadas del conjunto comprendido por cloruro de sodio en una concentración de entre 2,0 y 2,6 g/l, citrato de potasio de entre 1,8 y 2,5 g/l, citrato de sodio en una concentración de entre 2,2 y 2,9 g/l, y sus mezclas.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP140100123A AR094658A1 (es) | 2014-01-14 | 2014-01-14 | Formulación de sales de rehidratación liposomal |
MX2016009229A MX2016009229A (es) | 2014-01-14 | 2015-01-07 | Formulacion de sales de rehidratacion liposomal. |
BR112016016269A BR112016016269A2 (pt) | 2014-01-14 | 2015-01-07 | Formulação de sais de re-hidratação lipossomal |
AU2015207485A AU2015207485B2 (en) | 2014-01-14 | 2015-01-07 | Formulation of liposome rehydration salts |
PCT/ES2015/070003 WO2015107241A1 (es) | 2014-01-14 | 2015-01-07 | Formulación de sales de rehidratación liposomal |
US15/111,485 US20160331778A1 (en) | 2014-01-14 | 2015-01-07 | Formulation of liposome rehydration salts |
US15/723,241 US20180021372A1 (en) | 2014-01-14 | 2017-10-03 | Treatment methods for dehydration using liposomal rehydration salt formulation |
US15/723,228 US10238687B2 (en) | 2014-01-14 | 2017-10-03 | Method for preparing a liposomal rehydration salt formulation |
US15/797,031 US20180049983A1 (en) | 2014-01-14 | 2017-10-30 | Liposomal rehydration salt formulation and associated methods of use |
US16/554,797 US10751283B2 (en) | 2014-01-14 | 2019-08-29 | Liposomal rehydration salt formulation and associated methods of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP140100123A AR094658A1 (es) | 2014-01-14 | 2014-01-14 | Formulación de sales de rehidratación liposomal |
Publications (1)
Publication Number | Publication Date |
---|---|
AR094658A1 true AR094658A1 (es) | 2015-08-19 |
Family
ID=53542443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100123A AR094658A1 (es) | 2014-01-14 | 2014-01-14 | Formulación de sales de rehidratación liposomal |
Country Status (6)
Country | Link |
---|---|
US (4) | US20160331778A1 (es) |
AR (1) | AR094658A1 (es) |
AU (1) | AU2015207485B2 (es) |
BR (1) | BR112016016269A2 (es) |
MX (1) | MX2016009229A (es) |
WO (1) | WO2015107241A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR094658A1 (es) | 2014-01-14 | 2015-08-19 | Fast Rehydration Llc | Formulación de sales de rehidratación liposomal |
US10751283B2 (en) | 2014-01-14 | 2020-08-25 | Capability Building, Inc. | Liposomal rehydration salt formulation and associated methods of use |
WO2023230636A2 (en) * | 2022-05-27 | 2023-11-30 | The Coca-Cola Company | Fast hydration formulation and methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6534300B1 (en) * | 1999-09-14 | 2003-03-18 | Genzyme Glycobiology Research Institute, Inc. | Methods for producing highly phosphorylated lysosomal hydrolases |
EP2338478B1 (en) | 2002-06-28 | 2014-07-23 | Protiva Biotherapeutics Inc. | Method for producing liposomes |
US7112273B2 (en) * | 2002-09-27 | 2006-09-26 | Nxstage Medical, Inc. | Volumetric fluid balance control for extracorporeal blood treatment |
US20050008685A1 (en) * | 2003-07-07 | 2005-01-13 | Mitchell Cheryl R. | Oral rehydration compositions containing liposomes |
US20090017167A1 (en) * | 2007-07-11 | 2009-01-15 | Herbalife International Inc. | Mixture and beverage made therefrom for protecting cellular hydration |
NZ594995A (en) * | 2009-03-12 | 2013-06-28 | Alnylam Pharmaceuticals Inc | LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES |
AR094658A1 (es) | 2014-01-14 | 2015-08-19 | Fast Rehydration Llc | Formulación de sales de rehidratación liposomal |
-
2014
- 2014-01-14 AR ARP140100123A patent/AR094658A1/es unknown
-
2015
- 2015-01-07 BR BR112016016269A patent/BR112016016269A2/pt not_active Application Discontinuation
- 2015-01-07 AU AU2015207485A patent/AU2015207485B2/en not_active Ceased
- 2015-01-07 MX MX2016009229A patent/MX2016009229A/es unknown
- 2015-01-07 US US15/111,485 patent/US20160331778A1/en not_active Abandoned
- 2015-01-07 WO PCT/ES2015/070003 patent/WO2015107241A1/es active Application Filing
-
2017
- 2017-10-03 US US15/723,241 patent/US20180021372A1/en not_active Abandoned
- 2017-10-03 US US15/723,228 patent/US10238687B2/en active Active
- 2017-10-30 US US15/797,031 patent/US20180049983A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180021372A1 (en) | 2018-01-25 |
US20160331778A1 (en) | 2016-11-17 |
MX2016009229A (es) | 2017-03-06 |
BR112016016269A2 (pt) | 2017-08-08 |
US20180028561A1 (en) | 2018-02-01 |
US10238687B2 (en) | 2019-03-26 |
WO2015107241A1 (es) | 2015-07-23 |
US20180049983A1 (en) | 2018-02-22 |
AU2015207485B2 (en) | 2018-01-25 |
AU2015207485A1 (en) | 2016-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2015002066A1 (es) | Composiciones que incluye agentes para conferir carácter hidrofóbico y estabilizantes y métodos para elaborar y usar los mismos. | |
AR094643A1 (es) | Complejo de haluro de aminoácido y zinc con cisteína | |
BR112017011215A2 (pt) | partículas de distribuição de pró-flavorizante | |
MA38399A1 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
AR091959A1 (es) | Agentes de sosten sinteticos y agentes de sosten monodispersos y metodos para la elaboracion de los mismos | |
AR102203A1 (es) | Composiciones para el cuidado oral que comprenden zinc, arginina y serina | |
CO2017002506A2 (es) | Nuevos activadores de la guanilato ciclasa soluble y su uso | |
CL2014001060A1 (es) | Compuestos derivados de aril-quinolina; proceso de obtencion; composicion farmaceutica que los comprende y uso en el tratamiento o profilaxis de la diabetes tipo 2, la aterosclerosis, cancer, entre otras enfermedades. | |
EA201790627A1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
CY1123892T1 (el) | Κρυσταλλικες μορφες του 6-((6,7-διμεθοξυκιναζολιν-4-υλο)οξυ)-ν,2-διμεθυλοβενζοφουρανο-3-καρβοξαμιδιου | |
AR110378A1 (es) | Métodos para determinar el estado del cáncer colorrectal en una persona | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
ECSP16058769A (es) | Composicion para la administracion oral de agente bioactivos | |
AR094658A1 (es) | Formulación de sales de rehidratación liposomal | |
AR098024A1 (es) | Fármaco para la prevención y/o tratamiento de la poliquistosis renal | |
CL2016003155A1 (es) | Composiciones de cuidado bucal | |
AR106559A1 (es) | Suspensión acuosa para administración oral y método para su preparación | |
BR112017006918A2 (pt) | formulações nanoestruturadas para liberação de silibinina e outros ingredientes ativos para o tratamento de doenças oculares | |
UY37065A (es) | Método de purificación | |
CL2017000948A1 (es) | Textile compuesto que consiste en fibras naturales y/o sintéticas y/o artificiales y partículas lignocelulósicas | |
BR112018004244A2 (pt) | formulações sólidas de pirofosfato férrico solúvel, kits e seus métodos de uso | |
CO2017002963A2 (es) | Espiro-tiazolonas | |
CR20140526A (es) | Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis | |
AR101270A1 (es) | Composición abrasiva para el cuidado oral | |
CL2015001590A1 (es) | Composicion para el cuidado oral que comprende; (i) un agente blanqueador peroxido y (ii) un abrasivo en la forma de particulas que estan pre-recubiertas por un acido graso c2-c30 saturado, un acido graso c12-c30 mono-saturado, silicona, o sus mezclas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |